Lycia Therapeutics, Inc. (LYCA) income statement
LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.77+0.42 (+1.34%)
Close on Nov 19, 2026Market cap –P/E –Yield –
Lycia Therapeutics, Inc. financial ratios
Not enough reported data yet to compute ratios by period.
See a number that looks wrong?